Expression of SNRPF in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SNRPF is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 55.36

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

47.4

Number of samples

141

Samples

Sample	Description	TPM
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	89.5
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	76.7
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	74.1
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	70.5
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	70.5
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	70.1
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	69.8
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	69.6
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	67.9
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	67.5
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	66.7
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	65.7
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	64.6
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	64.3
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	63.9
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	63.9
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	62.9
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	62.2
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	61.6
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	61.6
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	60.8
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	60.4
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	60.3
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	59.4
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	59.1
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	59.0
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	58.8
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	58.7
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	58.6
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	58.6
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	58.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	58.1
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	57.1
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	56.9
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	56.9
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	56.7
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	56.0
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	55.4
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	55.3
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	55.3
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	55.3
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	55.1
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	54.4
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	53.5
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	52.8
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	52.3
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	51.6
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	51.5
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	50.8
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	50.4
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	50.3
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	49.9
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	49.8
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	49.7
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	49.5
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	49.3
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	47.7
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	47.5
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	47.4
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	47.4
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	46.9
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	46.6
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	46.3
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	46.1
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	45.9
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	45.7
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	45.3
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	45.3
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	45.2
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	45.0
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	44.6
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	44.6
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	44.5
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	44.3
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	44.2
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	43.9
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	43.8
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	43.7
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	43.6
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	43.3
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	42.8
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	42.7
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	42.5
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	42.3
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	42.3
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	41.8
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	41.7
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	41.7
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	41.6
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	41.4
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	41.1
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	41.1
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	40.8
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	40.8
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	40.6
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	40.6
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	40.4
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	40.1
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	40.1
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	39.8
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	39.5
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	39.1
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	38.9
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	38.7
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	38.5
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	38.4
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	38.1
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	37.9
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	37.9
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	37.8
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	37.7
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	37.6
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	37.4
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	37.4
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	37.0
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	36.8
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	36.7
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	36.5
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	36.5
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	36.2
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	36.2
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	36.0
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	35.9
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	35.0
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	35.0
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	34.9
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	34.9
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	34.7
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	34.3
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	34.2
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	33.7
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	32.3
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	32.0
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	29.8
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	29.1
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	28.9
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	28.3
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	27.3
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	25.6
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	23.7
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	23.3
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SNRPF is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 3.83

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

4.8

Number of samples

Samples

Sample	Description	TPM
AK002	N, NA, stage:NA, dead, 570 days	10.0
AK156	N, NA, stage:NA, dead, 330 days	9.0
AK085	N, NA, stage:NA, alive, 660 days	7.1
AK051	N, NA, stage:NA, dead, 360 days	6.9
AK043	N, NA, stage:NA, alive, 660 days	6.6
AK124	N, NA, stage:NA, alive, 1920 days	6.3
AK173	N, NA, stage:NA, dead, 180 days	6.0
AK117	N, NA, stage:NA, dead, 210 days	6.0
AK153	N, NA, stage:NA, dead, 240 days	5.9
AK081	N, NA, stage:NA, dead, 180 days	5.9
AK041	N, NA, stage:NA, alive, 810 days	5.9
AK123	N, NA, stage:NA, dead, 180 days	5.8
AK099	N, NA, stage:NA, dead, 420 days	5.8
AK102	N, NA, stage:NA, alive, 1740 days	5.8
AK079	N, NA, stage:NA, dead, 210 days	5.7
AK074	N, NA, stage:NA, alive, 300 days	5.6
AK218	N, NA, stage:NA, dead, 180 days	5.5
AK142	N, NA, stage:NA, alive, 90 days	5.4
AK133	N, NA, stage:NA, dead, 360 days	5.2
AK195	N, NA, stage:NA, dead, 390 days	5.2
AK236	N, NA, stage:NA, dead, 360 days	5.1
AK068	N, NA, stage:NA, alive, 360 days	5.1
AK035	N, NA, stage:NA, dead, 210 days	5.0
AK205	N, NA, stage:NA, dead, 120 days	4.9
AK185	N, NA, stage:NA, alive, 330 days	4.9
AK103	N, NA, stage:NA, alive, 1320 days	4.9
AK066	N, NA, stage:NA, alive, 960 days	4.8
AK231	N, NA, stage:NA, dead, 240 days	4.8
AK030	N, NA, stage:NA, dead, 120 days	4.8
AK089	N, NA, stage:NA, dead, 330 days	4.7
AK213	N, NA, stage:NA, alive, 2010 days	4.7
AK183	N, NA, stage:NA, alive, 360 days	4.6
AK071	N, NA, stage:NA, dead, 540 days	4.6
AK149	N, NA, stage:NA, dead, 420 days	4.6
AK226	N, NA, stage:NA, dead, 360 days	4.5
AK098	N, NA, stage:NA, dead, 660 days	4.5
AK165	N, NA, stage:NA, alive, 360 days	4.4
AK053	N, NA, stage:NA, dead, 300 days	4.3
AK134	N, NA, stage:NA, dead, 360 days	4.3
AK139	N, NA, stage:NA, dead, 270 days	4.2
AK072	N, NA, stage:NA, dead, 150 days	4.2
AK227	N, NA, stage:NA, alive, 300 days	4.1
AK199	N, NA, stage:NA, alive, 1860 days	4.0
AK015	N, NA, stage:NA, alive, 720 days	3.9
AK158	N, NA, stage:NA, dead, 360 days	3.9
AK003	N, NA, stage:NA, dead, 600 days	3.9
AK188	N, NA, stage:NA, alive, 420 days	3.8
AK216	N, NA, stage:NA, dead, 360 days	3.7
AK100	N, NA, stage:NA, alive, 960 days	3.7
AK178	N, NA, stage:NA, dead, 240 days	3.5
AK006	N, NA, stage:NA, dead, 360 days	3.4
AK005	N, NA, stage:NA, dead, 240 days	3.4
AK055	N, NA, stage:NA, dead, 240 days	3.4
AK076	N, NA, stage:NA, alive, 660 days	3.2
AK167	N, NA, stage:NA, dead, 180 days	3.2
AK091	N, NA, stage:NA, dead, 210 days	2.9
AK088	N, NA, stage:NA, dead, 360 days	2.9
AK049	N, NA, stage:NA, dead, 180 days	2.8
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218770003	Tumor	1.1
CPT0078580003	Tumor	0.9
CPT0217190003	Tumor	0.7
CPT0189570004	Tumor	0.6
CPT0123530003	Tumor	0.6
CPT0161730003	Tumor	0.6
CPT0224600003	Tumor	0.6
CPT0207090003	Tumor	0.6
CPT0206230003	Tumor	0.5
CPT0217000004	Tumor	0.5
CPT0206560003	Tumor	0.5
CPT0206780003	Tumor	0.5
CPT0167530003	Tumor	0.5
CPT0206670004	Tumor	0.4
CPT0224540004	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0092440003	Tumor	0.3
CPT0217710008	Tumor	0.3
CPT0218830004	Tumor	0.3
CPT0208980003	Tumor	0.3
CPT0228220003	Tumor	0.3
CPT0087680003	Tumor	0.3
CPT0217100003	Tumor	0.2
CPT0162140003	Tumor	0.2
CPT0182550003	Tumor	0.2
CPT0127480003	Tumor	0.2
CPT0093450003	Tumor	0.2
CPT0162100003	Tumor	0.2
CPT0168080003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0064890003	Tumor	0.1
CPT0224390004	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0217430008	Tumor	0.1
CPT0168590003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0218890004	Tumor	0.1
CPT0087950003	Tumor	0.0
CPT0218690004	Tumor	0.0
CPT0218330004	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0002410011	Tumor	0.0
CPT0189850004	Tumor	0.0
CPT0182500003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0093360003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0190240004	Tumor	0.0
CPT0168480003	Tumor	0.0
CPT0171580008	Tumor	0.0
CPT0217880003	Tumor	0.0
CPT0162020003	Tumor	-0.1
CPT0089150003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0127420003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0093510003	Tumor	-0.1
CPT0218960004	Tumor	-0.1
CPT0087730003	Tumor	-0.1
CPT0189250003	Tumor	-0.1
CPT0205570003	Tumor	-0.1
CPT0186100003	Tumor	-0.1
CPT0182580003	Tumor	-0.1
CPT0104330003	Tumor	-0.2
CPT0217060003	Tumor	-0.2
CPT0225760003	Tumor	-0.2
CPT0201710003	Tumor	-0.2
CPT0125570003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0168830003	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0218670003	Tumor	-0.2
CPT0093590003	Tumor	-0.2
CPT0125220003	Tumor	-0.2
CPT0190360004	Tumor	-0.2
CPT0087570003	Tumor	-0.3
CPT0199770003	Tumor	-0.3
CPT0205450004	Tumor	-0.3
CPT0225730003	Tumor	-0.3
CPT0207030003	Tumor	-0.3
CPT0224330003	Tumor	-0.3
CPT0209440003	Tumor	-0.3
CPT0189750004	Tumor	-0.3
CPT0221180003	Tumor	-0.3
CPT0189460003	Tumor	-0.3
CPT0079790003	Tumor	-0.3
CPT0216920008	Tumor	-0.4
CPT0206880003	Tumor	-0.4
CPT0196850003	Tumor	-0.4
CPT0204350003	Normal	-0.4
CPT0175060003	Tumor	-0.4
CPT0168270003	Tumor	-0.4
CPT0206110003	Tumor	-0.4
CPT0206330003	Tumor	-0.5
CPT0189650004	Tumor	-0.5
CPT0206450003	Tumor	-0.5
CPT0204370003	Normal	-0.5
CPT0204380003	Normal	-0.5
CPT0219080004	Tumor	-0.6
CPT0204330003	Normal	-0.7
CPT0204400003	Normal	-0.7
CPT0204340003	Normal	-0.8
CPT0204360003	Normal	-0.8
CPT0104220003	Tumor	-0.8
CPT0204420003	Normal	-0.9
CPT0204390003	Normal	-0.9
CPT0204410003	Normal	-1.1
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis